Seegene Inc
상단으로
Contact Us

Product News You can check out the latest product information

  • Obtained Australian TGA approval for Allplex™ NG-DR Assay

    Seegene has received approval from Australia’s Therapeutic Goods Administration for Allplex™ NG-DR Assay. Therapeutic goods must be entered in the Australian Register of Therapeutic Goods before they can be supplied in the country.

    Sep 14, 2022 Allplex™ NG & DR Assay

  • Obtained approval of MFDS for AnyplexII™ STI-12 Detection

    AnyplexII™ STI-12 Detection has received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a multiplex real-time PCR assay for detection of Candida albicans, Chlamydia trachomatis, Gardnerella vaginalis, Herpes simplex virus type 1, Herpes simplex virus type 2, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, Ureaplasma parvum and Ureaplasma urealyticum.

    Feb 13, 2020 Anyplex™Ⅱ STI-12 Detection

  • Obtained CE-IVD marking for Allplex™ STI Essential Assay Q(MH,UU)

    Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ STI Essential Assay Q(MH,UU). This assays?is a multiplex real-time PCR assay to simultaneously detect 7 pathogens causing sexually transmitted infections. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct value or quantitative result of each pathogen in a single channel. The quantitative result of Mycoplasma hominis and Ureaplasma urealyticum helps effective management of STIs.

    May 30, 2019 Allplex™ STI Essential Assay Q(MH,UU)

  • Obtained CE-IVD marking for Allplex™ Vaginitis Screening Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ Vaginitis Screening Assay. This assay is a Multiplex Real-time PCR assay that detects and identifies major pathogens related vaginitis simultaneously. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct values of each pathogen in a single channel. And it provides automated interpretation of BV using Seegene Viewer based on quantification information of major targets.

    Jan 25, 2019 Allplex™ Vaginitis Screening Assay

  • Obtained CE-IVD marking for Allplex™ MG & AziR Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ MG & AziR Assay. This assays?is a multiplex real-time PCR assay that detects and identifies?Mycoplasma genitalium?(MG) and 6 mutations causing azithromycin resistance. Azithromycin is generally prescribed for 1st-line treatment of MG. Based on Seegene’s proprietary DPO™ & MuDT™ Technology, this assay enables to check MG infection and azithromycin resistance in a single test and reports multiple Ct?values of each pathogen in a single tube.

    Oct 29, 2018 Allplex™ MG & AziR Assay

  • Obtained CE-IVD marking for Allplex™ Bacterial Vaginosis Assay

    Allplex™ Bacterial Vaginosis Assay simultaneously detects 7 bacteria (G. vaginalis, A. vaginae, Megasphaera type 1, BV-associated bacteria 2, Mobiluncus spp., B. fragilis, Lactobacillus spp.) associated with vaginosis. It provides quantitative information of 3 major bacteria (G. vaginalis, A. vaginae, Lactobacillus spp.).   Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report individual Ct  value of multiple bacteria in a single channel. The CE-IVD mark will allow more opportunities for Seegene to market and sell within the European Union.

    Dec 15, 2016 Allplex™ Bacterial Vaginosis Assay

  • Obtained CE-IVD marking for Allplex™ Genital ulcer Assay and Allplex™ Candidiasis Assay

    Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ Genital ulcer Assay and Allplex™ Candidiasis Assay. Allplex™ Genital ulcer Assay detects 7 pathogens (HSV1, HSV2, CMV, VZV, LGV related CMV, T. pallidum, H. ducreyi ) causing genital ulcer simultaneously. Allplex™ Candidiasis Assay detects and differentiate 7 candida spp.(C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. lusitaniae, C. dubliniensis )  causing candidiasis simultaneously. Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report multiple Ct values of each pathogen in a single channel using real-time PCR instruments.The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Oct 14, 2016 Allplex™ Candidiasis Assay

  • Launched Allplex™ STI Essential Assay

    Allplex™ STI Essential Assay is a multiplex real-time PCR test that can simultaneously detect seven of the more common causes of STIs from a wide range of specimen types including genital swab, urine and liquid based cytology specimen. The Allplex™ STI Essential Assay will provide clinicians with a powerful tool to help protect health and prevent the spread of STIs.

    May 01, 2016 Allplex™ STI Essential Assay